{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:00:34Z","timestamp":1774929634178,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"DOI":"10.7759\/cureus.106164","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:43:21Z","timestamp":1774925001000},"source":"Crossref","is-referenced-by-count":0,"title":["Association Between Insulin Resistance Markers and Immunological Markers in Gestational Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Vandana","family":"Tiwary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monisha","family":"M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhabani","family":"Pegu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195736","article-title":"Gestational diabetes mellitus-recent literature review","volume":"11","author":"Modzelewski R","year":"2022","unstructured":"Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. Gestational diabetes mellitus-recent literature review. J Clin Med. 2022, 11:5736. 10.3390\/jcm11195736","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1112","article-title":"Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations with neonatal anthropometrics","volume":"58","author":"HAPO Study Cooperative Research Group","year":"2009","unstructured":"HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009, 58:453-9. 10.2337\/db08-1112","journal-title":"Diabetes"},{"key":"ref3","unstructured":"Diabetes atlas. (2026). https.\/\/diabetesatlas.org\/resources\/previous-editions\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113342","article-title":"The pathophysiology of gestational diabetes mellitus","volume":"19","author":"Plows JF","year":"2018","unstructured":"Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018, 19:3342. 10.3390\/ijms19113342","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1399694","article-title":"Genetic and inflammatory factors underlying gestational diabetes mellitus: a review","volume":"15","author":"Ray GW","year":"2024","unstructured":"Ray GW, Zeng Q, Kusi P, et al.. Genetic and inflammatory factors underlying gestational diabetes mellitus: a review. Front Endocrinol (Lausanne). 2024, 15:1399694. 10.3389\/fendo.2024.1399694","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-12668-1_12","article-title":"The role of inflammation in the development of GDM and the use of markers of inflammation in GDM screening","volume":"1134","author":"Khambule L","year":"2019","unstructured":"Khambule L, George JA. The role of inflammation in the development of GDM and the use of markers of inflammation in GDM screening. Adv Exp Med Biol. 2019, 1134:217-42. 10.1007\/978-3-030-12668-1_12","journal-title":"Adv Exp Med Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1042\/CS20050363","article-title":"Increased visfatin concentrations in women with gestational diabetes mellitus","volume":"110","author":"Krzyzanowska K","year":"2006","unstructured":"Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, Schernthaner G. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond). 2006, 110:605-9. 10.1042\/CS20050363","journal-title":"Clin Sci (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.25259\/IJMR_1874_2025","article-title":"Prevalence of gestational diabetes mellitus in India: the ICMR-INDIAB national study (ICMR-INDIAB-24)","volume":"162","author":"Mohan V","year":"2025","unstructured":"Mohan V, Deepa M, Tandon N, et al.. Prevalence of gestational diabetes mellitus in India: the ICMR-INDIAB national study (ICMR-INDIAB-24). Indian J Med Res. 2025, 162:460-9. 10.25259\/IJMR_1874_2025","journal-title":"Indian J Med Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116279","article-title":"New insights into adipokines in gestational diabetes mellitus","volume":"23","author":"Valencia-Ortega J","year":"2022","unstructured":"Valencia-Ortega J, Gonz\u00e1lez-Reynoso R, Ramos-Mart\u00ednez EG, Ferreira-Hermosillo A, Pe\u00f1a-Cano MI, Morales-\u00c1vila E, Saucedo R. New insights into adipokines in gestational diabetes mellitus. Int J Mol Sci. 2022, 23:6279. 10.3390\/ijms23116279","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.20020","article-title":"Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus","volume":"63","author":"Amirian A","year":"2020","unstructured":"Amirian A, Mahani MB, Abdi F. Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus. Obstet Gynecol Sci. 2020, 63:407-16. 10.5468\/ogs.20020","journal-title":"Obstet Gynecol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1957820","article-title":"Interleukin-10 levels and risk of gestational diabetes mellitus: a systematic review and meta-analysis","volume":"35","author":"Ni J","year":"2022","unstructured":"Ni J, Wang Y, Zhu J, Zheng T, Yu J, Xiong Y. Interleukin-10 levels and risk of gestational diabetes mellitus: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2022, 35:7609-16. 10.1080\/14767058.2021.1957820","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref12","article-title":"Role of Arg1+ ILC2s and ILCregs in gestational diabetes progression","volume":"15","author":"Gong Z","year":"2025","unstructured":"Gong Z, Yi H, Zhang J, et al.. Role of Arg1+ ILC2s and ILCregs in gestational diabetes progression. Sci Rep. 2025, 15:1580.","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2021.1874997","article-title":"Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis","volume":"127","author":"Jiang YK","year":"2021","unstructured":"Jiang YK, Deng HY, Qiao ZY, Gong FX. Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis. Arch Physiol Biochem. 2021, 127:468-78. 10.1080\/13813455.2021.1874997","journal-title":"Arch Physiol Biochem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146622","article-title":"The association between chemerin levels and gestational diabetes mellitus: an updated systematic review and meta-analysis","volume":"26","author":"Aldharee H","year":"2025","unstructured":"Aldharee H, Makki YR, Hamdan HZ. The association between chemerin levels and gestational diabetes mellitus: an updated systematic review and meta-analysis. Int J Mol Sci. 2025, 26:6622. 10.3390\/ijms26146622","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.07.018","article-title":"Role of immunological markers in gestational diabetes mellitus-a brief review","volume":"13","author":"Siddiqui S","year":"2019","unstructured":"Siddiqui S, Waghdhare S, Jha S, Dubey S. Role of immunological markers in gestational diabetes mellitus-a brief review. Diabetes Metab Syndr. 2019, 13:2983-5. 10.1016\/j.dsx.2018.07.018","journal-title":"Diabetes Metab Syndr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger BE","year":"2010","unstructured":"Metzger BE, Gabbe SG, Persson B, et al.. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33:676-82. 10.2337\/dc09-1848","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11646","article-title":"New born macrosomia in gestational diabetes mellitus","volume":"24","author":"Bernea EG","year":"2022","unstructured":"Bernea EG, Uyy E, Mihai DA, et al.. New born macrosomia in gestational diabetes mellitus. Exp Ther Med. 2022, 24:710. 10.3892\/etm.2022.11646","journal-title":"Exp Ther Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20032102","article-title":"Association between maternal blood glucose levels during pregnancy and birth outcomes: a birth cohort study","volume":"20","author":"Zhao D","year":"2023","unstructured":"Zhao D, Liu D, Shi W, et al.. Association between maternal blood glucose levels during pregnancy and birth outcomes: a birth cohort study. Int J Environ Res Public Health. 2023, 20:2102. 10.3390\/ijerph20032102","journal-title":"Int J Environ Res Public Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S417632","article-title":"Is chemerin associated with gestational diabetes mellitus? A case-control study","volume":"16","author":"Ma Z","year":"2023","unstructured":"Ma Z, Chu L, Zhang Y, Lu F, Zhu Y, Wu F, Zhang Z. Is chemerin associated with gestational diabetes mellitus? A case-control study. Diabetes Metab Syndr Obes. 2023, 16:2271-81. 10.2147\/DMSO.S417632","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-018-0826-1","article-title":"Circulating chemerin levels and gestational diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Zhou Z","year":"2018","unstructured":"Zhou Z, Chen H, Ju H, Sun M. Circulating chemerin levels and gestational diabetes mellitus: a systematic review and meta-analysis. Lipids Health Dis. 2018, 17:169. 10.1186\/s12944-018-0826-1","journal-title":"Lipids Health Dis"},{"key":"ref21","article-title":"Association of gestational diabetes and proinflammatory cytokines (IL-6, TNF-\u03b1 and IL-1\u03b2)","volume":"1","author":"Gelen V","year":"2017","unstructured":"Gelen V, \u015eeng\u00fcl E, Atila G, Uslu H, Makav M. Association of gestational diabetes and proinflammatory cytokines (IL-6, TNF-\u03b1 and IL-1\u03b2). J Embryo. 2017, 1:6-11.","journal-title":"J Embryo"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-023-01188-3","article-title":"Association between serum interleukin-6, leptin and insulin in gestational diabetes mellitus - a cross- sectional study","volume":"22","author":"Srivastava N","year":"2023","unstructured":"Srivastava N, Singh K, Singh N, Mahdi AA. Association between serum interleukin-6, leptin and insulin in gestational diabetes mellitus - a cross- sectional study. J Diabetes Metab Disord. 2023, 22:639-48. 10.1007\/s40200-023-01188-3","journal-title":"J Diabetes Metab Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11435","article-title":"Gestational diabetes and T-cell (Th1\/Th2\/Th17\/Treg) immune profile","volume":"33","author":"Sifnaios E","year":"2019","unstructured":"Sifnaios E, Mastorakos G, Psarra K, et al.. Gestational diabetes and T-cell (Th1\/Th2\/Th17\/Treg) immune profile. In Vivo. 2019, 33:31-40. 10.21873\/invivo.11435","journal-title":"In Vivo"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.157041","article-title":"Role of macrophages reprogramming in pathogenesis of gestational diabetes mellitus","volume":"196","author":"Milan KL","year":"2025","unstructured":"Milan KL, Shree RA, Nandana N, Leela R, Ramkumar KM. Role of macrophages reprogramming in pathogenesis of gestational diabetes mellitus. Cytokine. 2025, 196:157041. 10.1016\/j.cyto.2025.157041","journal-title":"Cytokine"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.12.017","article-title":"Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue","volume":"84","author":"Telejko B","year":"2009","unstructured":"Telejko B, Kuzmicki M, Zonenberg A, et al.. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue. Diabetes Res Clin Pract. 2009, 84:68-75. 10.1016\/j.diabres.2008.12.017","journal-title":"Diabetes Res Clin Pract"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12385","article-title":"Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus","volume":"7","author":"Liang Z","year":"2016","unstructured":"Liang Z, Wu Y, Xu J, Fang Q, Chen D. Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus. J Diabetes Investig. 2016, 7:247-52. 10.1111\/jdi.12385","journal-title":"J Diabetes Investig"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/472193-association-between-insulin-resistance-markers-and-immunological-markers-in-gestational-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:43:28Z","timestamp":1774925008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/472193-association-between-insulin-resistance-markers-and-immunological-markers-in-gestational-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.106164","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}